PTSD study: PATH-SS
Official title Positive Processes and Transition to Health - Single-Session (PATH-SS)
ClinicalTrials.gov ID: NCT06900712
What this study is testing
- What it's testing
- The study tests whether the new therapy, PATH‑SS, can lower distress from sexual assault, including PTSD and depression, and whether participants find it helpful and complete it.
- Who it's for
- Adults who have experienced sexual assault and have PTSD or depression symptoms.
- What's involved
- Participants first complete a baseline assessment, then receive one therapy session, followed by a post‑treatment assessment and a 1‑month follow‑up to measure symptoms.
- Time commitment
- The study lasts about one month, with a baseline visit, one therapy session, a post‑treatment visit, and a 1‑month follow‑up visit.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Age range: from 18 to 65.
- Has experienced unwanted sexual contact or sexual assault with a minimum of 12 weeks since the event and a maximum of 5 years since the event.
- Residence in the state of Ohio.
- Elevated symptoms on either the Posttraumatic Diagnostic Scale (PDS-5) or the Quick Inventory of Depressive Symptomatology (QIDS-SR), at least...
You likely can't join if
- Current diagnosis of schizophrenia, delusional disorder, or organic mental disorder as defined by DSM-5.
- Current diagnosis of bipolar disorder, depression with psychotic features, or depression severe enough to require immediate psychiatric treatment...
- Severe self-injurious behavior or suicide attempt within the previous three months.
- Currently engaged in cognitive behavioral psychotherapy.
- No clear memory of the event.
- Unstable dose of psychotropic medications in prior 3 months.
See the full eligibility criteria
- Age range: from 18 to 65.
- Has experienced unwanted sexual contact or sexual assault with a minimum of 12 weeks since the event and a maximum of 5 years since the event.
- Residence in the state of Ohio.
- Elevated symptoms on either the Posttraumatic Diagnostic Scale (PDS-5) or the Quick Inventory of Depressive Symptomatology (QIDS-SR), at least moderate: 18 on PDS-5 (Foa et al., 2016) and/or 11 on QIDS (moderate...
- Current diagnosis of schizophrenia, delusional disorder, or organic mental disorder as defined by DSM-5.
- Current diagnosis of bipolar disorder, depression with psychotic features, or depression severe enough to require immediate psychiatric treatment (i.e., serious suicide risk with intent and plan).
- Severe self-injurious behavior or suicide attempt within the previous three months.
- Currently engaged in cognitive behavioral psychotherapy.
- No clear memory of the event.
- Unstable dose of psychotropic medications in prior 3 months.
- Ongoing intimate relationship with the perpetrator.
- Current diagnosis of a substance use disorder (DSM-5).
- Residence outside the state of Ohio.
The study team makes the final eligibility decision.
Where it is enrolling
- Cleveland, Ohio, United States
Compensation & support
A stipend or payment for your time may be offered.
No amount is published here because ClinicalTrials.gov has no reliable field for payment or travel support. Ask the study team what's actually covered (payment for your time, travel, parking, or other study costs), and never join a trial for the compensation alone.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team, so confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Cleveland, Ohio, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.